Raasch B. Clinical, Cosmetic and Investigational Dermatology. 9 June 2009.
There is reasonable evidence that the use of imiquimod for small (<2 cm) superficial BCC that occur other than on the face provides
outcomes only marginally less satisfactory t
To date one long-term study indicates a treatment success rate of 78%-81% and that initial response is a predictor of long-term outcome. Recurrences tend to occur within the first year after treatment. Future research will compare this preparation to the gold standard treatment for superficial BCC - surgical excision.